[HTML][HTML] Chemotherapy side-effects: not all DNA damage is equal
WMC van den Boogaard, DSJ Komninos, WP Vermeij - Cancers, 2022 - mdpi.com
Simple Summary The number of children and adults with cancer that are completely cured is
still increasing thanks to effective anti-cancer therapy, but they may be confronted with the …
still increasing thanks to effective anti-cancer therapy, but they may be confronted with the …
Cancer therapy–related hypertension: a scientific statement from the American Heart Association
Contemporary anticancer drugs have significantly improved cancer survival at the expense
of cardiovascular toxicities, including heart disease, thromboembolic disease, and …
of cardiovascular toxicities, including heart disease, thromboembolic disease, and …
Hypertension in cancer patients and survivors: epidemiology, diagnosis, and management
JB Cohen, AS Geara, JJ Hogan, RR Townsend - Cardio Oncology, 2019 - jacc.org
Cancer patients and survivors of cancer have a greater burden of cardiovascular disease
compared with the general population. Much of the elevated cardiovascular risk in these …
compared with the general population. Much of the elevated cardiovascular risk in these …
[HTML][HTML] Late-onset kidney failure in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study
BV Dieffenbach, Q Liu, AJ Murphy, DR Stein… - European Journal of …, 2021 - Elsevier
Background The incidence of and risk factors for late-onset kidney failure among survivors
over the very long term remains understudied. Materials and methods A total of 25,530 …
over the very long term remains understudied. Materials and methods A total of 25,530 …
Kidney function after treatment for childhood cancer: a report from the St. Jude Lifetime Cohort Study
DM Green, M Wang, M Krasin… - Journal of the …, 2021 - journals.lww.com
Background Survivors of childhood cancer may be at increased risk for treatment-related
kidney dysfunction. Although associations with acute kidney toxicity are well described …
kidney dysfunction. Although associations with acute kidney toxicity are well described …
Management of hypertension in patients with cancer: challenges and considerations
S Pandey, A Kalaria, KD Jhaveri… - Clinical Kidney …, 2023 - academic.oup.com
The survival rates of many cancers have significantly improved due to recent advancements
in cancer screening and therapeutics. Although better cancer outcomes are encouraging …
in cancer screening and therapeutics. Although better cancer outcomes are encouraging …
[HTML][HTML] Hypertension management in cardio-oncology
H Essa, R Dobson, D Wright, GYH Lip - Journal of human hypertension, 2020 - nature.com
Cancer is one of the leading causes of death worldwide. During the last few decades
prognosis has improved dramatically and patients are living longer and suffering long-term …
prognosis has improved dramatically and patients are living longer and suffering long-term …
[HTML][HTML] Physiology, glomerular filtration rate
DP Kaufman, H Basit, SJ Knohl - 2018 - europepmc.org
Glomerular filtration rate (GFR) represents the flow of plasma from the glomerulus into
Bowman's space over a specified period and is the chief measure of kidney function. The …
Bowman's space over a specified period and is the chief measure of kidney function. The …
Severe fatigue after treatment for childhood cancer
S van Deuren, A Boonstra… - Cochrane Database …, 2020 - cochranelibrary.com
Background Treatment strategies for childhood cancer are improving, resulting in higher
survival rates. However, the consequences of childhood cancer do not end with the …
survival rates. However, the consequences of childhood cancer do not end with the …
Onco-hypertension: an emerging specialty
P Gudsoorkar, R Ruf, H Adnani, K Safdar… - Advances in Chronic …, 2021 - Elsevier
Cancer is one of the leading causes of death worldwide. With the introduction of newer
chemotherapeutic agents, targeted therapies, and immunotherapy, the prognosis and …
chemotherapeutic agents, targeted therapies, and immunotherapy, the prognosis and …